Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Long-Term Deferred Tax (2019 - 2020)

Silence Therapeutics' Long-Term Deferred Tax history spans 1 years, with the latest figure at $30857.4 for Q4 2019.

  • For Q4 2019, Long-Term Deferred Tax changed N/A year-over-year to $30857.4; the TTM value through Dec 2019 reached $30857.4, changed N/A, while the annual FY2019 figure was $30644.1, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2019 was $30857.4 at Silence Therapeutics.
  • Across five years, Long-Term Deferred Tax topped out at $30857.4 in Q4 2019 and bottomed at $30857.4 in Q4 2019.